The DOI matches its Crossref record.
What Price Data Tell Us about Drug Markets
Open accessAbstract
This paper reviews empirical evidence on drug prices and discusses implications for understanding of drug markets and for policy. The most striking characteristics of drug prices are their high levels and extreme variability over time and space. High prices deter consumption but have ambiguous effects on drug-related crime. The consequences of the variability are largely unexplored and are difficult to determine. Conclusions are mixed with respect to the ability of policy to influence prices. Prohibition plus some degree of enforcement can drive prices far above what they would be if drugs were legal. In certain circumstances, additional severity of enforcement can create transient spikes in price or alter the source of drugs by driving up prices from one source relative to another. However, increasing enforcement over and above an already strongly enforced prohibition appears to have only limited ability to drive prices up further.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Levi, M., & Reuter, P. (2006) · Crime and Justice · doi:10.1086/501508 · Cited by 303
Self-citationEconomists’ Contribution to the Study of Crime and the Criminal Justice System
Bushway, S., & Reuter, P. (2008) · Crime and Justice · doi:10.1086/524283 · Cited by 71
Self-citationHow to Improve the Surveillance of the Taliban Ban’s Impact on European Drug Markets
Giommoni, L. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104320 · Cited by 9
Metadata
- Authors
- Caulkins, J. P., & Reuter, P.
- Venue
- Journal of Drug Issues
- Publisher
- SAGE Publications
- Published
- 1998-07
- Volume
- 28
- Issue
- 3
- Pages
- 593-612
- ISSN
- 0022-0426 (ISSN-L)
- 1945-1369
- OpenAlex
- W97080307
- Cited by
- 264
- References
- 0
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: What Price Data Tell Us about Drug Markets. https://app.cochat.ai/papers/10.1177/002204269802800302
- The paper
- Caulkins, J. P., & Reuter, P. (1998). What Price Data Tell Us about Drug Markets. Journal of Drug Issues. https://doi.org/10.1177/002204269802800302
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
